Plasma membrane transporters Alp1 and Nrt1 mediate the uptake of benzamidine conjugates in fungi.
Alp1 and Nrt1 transporters are crucial for the uptake and antifungal activity of benzamidine conjugates in fungi, offering insights into overcoming resistance.
Where it sits
this study against the rest of the tesofensine corpusSummary and findings
The study investigates the role of plasma membrane transporters Alp1 and Nrt1 in the uptake of benzamidine conjugates in fungi. It was found that these transporters are crucial for the antifungal activity of the conjugates. The research highlights a potential mechanism for overcoming antifungal resistance.
Abstract
Efflux pumps confer antifungal resistance. Benzamidine (BM) conjugates overcome resistance by enhancing intracellular accumulation, but their cellular uptake mechanism remains unclear. A screen of membrane transport protein mutants revealed that plasma membrane transporters Alp1 and Nrt1 are importers of BM conjugates and are essential for their antifungal activity.
Background
The study addresses the challenge of antifungal resistance, which is often mediated by efflux pumps that reduce intracellular drug concentrations. Benzamidine conjugates have been shown to bypass this resistance by increasing intracellular accumulation, but the specific uptake mechanisms were previously unknown. Understanding these mechanisms is crucial for developing effective antifungal therapies.
Methods
The researchers conducted a screen of membrane transport protein mutants in fungi to identify which transporters facilitate the uptake of benzamidine conjugates. The study focused on the role of plasma membrane transporters Alp1 and Nrt1 in mediating this uptake.
Results
The primary finding is that the plasma membrane transporters Alp1 and Nrt1 are essential for the import of benzamidine conjugates into fungal cells. This uptake is necessary for the conjugates' antifungal activity, suggesting a targeted mechanism to overcome resistance.
Interpretation
The identification of Alp1 and Nrt1 as key transporters for benzamidine conjugates provides a new understanding of how these compounds can overcome antifungal resistance. While the findings are significant for fungal biology, their clinical relevance in human antifungal therapy remains to be established. The study's reliance on fungal models limits its immediate applicability to human medicine.
Key findings
- Alp1 and Nrt1 are identified as importers of benzamidine conjugates.
- Benzamidine conjugates enhance intracellular accumulation.
- Transporters are essential for antifungal activity.
Limitations
- fungal model only, no human data
- mechanistic study, not clinical
- no quantitative data on uptake efficiency